Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -2.27EBITDA per Share
VS
Market
Sector
Industry
History
$ 3.35Close
$ 2.28 - $ 11.2 52-Week Range
Ticker Information
Ticker
PTIXCompany Name
PROTAGENIC THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPROTAGENIC THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PTIX - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -8.4M | $ -2.27 | 1 | 3.7M |
| 3/31/2025 | $ -5.19M | $ -9.92 | 1 | 523.18K |
| 12/31/2024 | $ -5.48M | $ -15.64 | 1 | 350K |
| 9/30/2024 | $ -5.57M | $ -17.22 | 1 | 323.51K |
| 6/30/2024 | $ -6.31M | $ -19.87 | 1 | 317.37K |
| 3/31/2024 | $ -5.89M | $ -18.59 | 1 | 316.8K |
| 12/31/2023 | $ -4.86M | $ -15.68 | 1 | 310.33K |
| 9/30/2023 | $ -3.8M | $ -12.27 | 1 | 309.35K |
| 6/30/2023 | $ -3.33M | $ -10.76 | 1 | 309.35K |
| 3/31/2023 | $ -2.78M | $ -9 | 1 | 308.42K |
Key Performance Insights, Last 5 Years
- PROTAGENIC THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -14.68.
- Over the past 5 years, PROTAGENIC THERAPEUTICS INC's average EBITDAPS has been $ -13.27.
- The median EBITDAPS for PROTAGENIC THERAPEUTICS INC during this period was $ -13.11
- PROTAGENIC THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ -2.27.
- The lowest EBITDAPS recorded by PROTAGENIC THERAPEUTICS INC in the same timeframe $ -19.87
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for PROTAGENIC THERAPEUTICS INC is calculated as follows: EBITDA [ $ -2.69M ] / (Shares WA [ 183.5K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -14.68 ] PTIX - EBITDA per Share, Last 5 years
$ -19.87
Minimum
Jun 30, 2024
$ -2.27
Maximum
Jun 30, 2025
$ -13.27
Average
$ -13.11
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 14.03 |
| average | $ 2.03 |
| median | $ 1 |
| std | $ 4.28 |